TSS
UTHR icon

Two Sigma Securities’s United Therapeutics UTHR Stock Holding History

Two Sigma Securities’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,900
Closed -$1.4M – 3241
2024
Q3 		$1.4M Sell
3,900
-15,900
-80% -$5.37M 0.02% 715
2024
Q2 		$6.31M Buy
19,800
+12,100
+157% +$3.2M 0.08% 292
2024
Q1 		$1.77M Buy
+7,700
New +$1.74M 0.02% 817
2023
Q4 		– Sell
-5,100
Closed -$1.15M – 3620
2023
Q3 		$1.15M Buy
5,100
+2,800
+122% +$645K 0.01% 950
2023
Q2 		$508K Buy
2,300
+300
+15% +$66.5K 0.01% 1423
2023
Q1 		$448K Sell
2,000
-200
-9% -$49.3K 0.01% 1342
2022
Q4 		$612K Buy
+2,200
New +$555K 0.02% 955
2019
Q2 		– Sell
-3,400
Closed -$399K – 2437
2019
Q1 		$399K Buy
+3,400
New +$396K ﹤0.01% 1007

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Two Sigma Securities's UTHR Position: Q2 2026 in Review

Two Sigma Securities increased its United Therapeutics (UTHR) stake by 435% in Q2 2026, buying an estimated $1.25M and bringing the position to 2,726 shares worth $1.48M. The position accounts for 0.13% of the portfolio, ranked #172.

Two Sigma Securities first reported a position in UTHR in Q3 2015 and has held it in 16 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Two Sigma Securities held 2,726 shares of United Therapeutics worth $1.48M as of Q2 2026.
  • Two Sigma Securities bought 2,216 United Therapeutics shares in Q2 2026, an estimated $1.25M.
  • United Therapeutics made up 0.13% of Two Sigma Securities's portfolio in Q2 2026, its #172 holding.
  • Two Sigma Securities first reported a position in United Therapeutics in Q3 2015 and has held it in 16 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.